Skip to main content

Table 2 The odds ratio [95% confidence interval] of monthly mortality rates of An. marajoara after 24 h post-exposure to alpha-cypermethrin, etofenprox WP, and lambda-cyhalothrin CS on four different surfaces: plastered cement wall (CP1), unplastered cement wall (CP2), painted wooden wall (WP1), and the unpainted wooden wall (WP2)

From: Efficacy of insecticides used in indoor residual spraying for malaria control: an experimental trial on various surfaces in a “test house”

Insecticide

Substrate

Days post IRS

1

30

60

90

120

150

180

210

240a

Alpha-cypermethrin SC

WP1

1.00 [0.78, 1.28]

1.00 [0.81, 1.24]

0.99 [0.73, 1.34]

0.77 [0.57, 1.05]

0.81 [0.59, 1.10]

0.49 [0.34, 0.70]

0.24 [0.15, 0.38]

WP2

0.83 [0.64, 1.08]

0.91 [0.73, 1.14]

0.45 [0.31, 0.66]

0.42 [0.28, 0.61]

CP1

0.98 [0.77, 1.26]

0.7 [0.57, 1.04]

0.21 [0.13, 0.35]

CP2

0.97 [0.73, 1.28]

0.51 [0.36, 0.71]

0.50 [0.36, 0.70]

Etofenprox WP

WP1

1.00 [0.79, 1.27]

1.00 [0.73, 1.37]

0.85 [0.62, 1.15]

0.81 [0.59, 1.12]

0.57 [0.40, 0.82]

0.29 [0.19, 0.45]

WP2

1.00 [0.80, 1.25]

0.96 [0.72, 1.28]

0.98 [0.73, 1.31]

0.97 [0.72, 1.30]

0.86 [0.64, 1.16]

0.68 [0.49, 0.94]

0.34 [0.23, 0.50]

CP1

1.00 [0.79, 1.26]

0.92 [0.70, 1.22]

0.86 [0.64, 1.17]

0.40 [0.27, 0.59]

0.52 [0.36, 0.73]

CP2

0.97 [0.77, 1.23]

0.66 [0.48, 0.91]

0.53 [0.37, 0.77]

Lambda-cyhalothrin WP

WP1

0.99 [0.79, 1.25]

0.98 [0.72, 1.32]

0.65 [0.46, 0.91]

0.42 [0.29, 0.62]

WP2

0.96 [0.77, 1.19]

0.96 [0.72, 1.28]

0.72 [0.53, 0.98]

0.62 [0.44, 0.87]

CP1

0.88 [0.70, 1.11]

0.78 [0.57, 1.05]

0.02 [0.01, 0.09]

CP2

0.98 [0.77, 1.24]

0.73 [0.53, 1.00]

0.58 [0.39, 0.86]

Deltamethrin WG

WP1

1.00 [0.74, 1.36]

1.00 [0.77, 1.30]

0.97 [0.75, 1.26]

0.97 [0.74, 1.27]

0.95 [0.75, 1.21]

0.94 [0.74, 1.19]

0.84 [0.64, 1.11]

0.82 [0.61, 1.10]

0.83 [0.65, 1.06]

WP2

1.00 [0.74, 1.35]

0.97 [0.76, 1.26]

0.59 [0.45, 0.78]

0.94 [0.70, 1.25]

0.94 [0.73, 1.20]

0.93 [0.73, 1.19]

0.92 [0.70, 1.20]

0.97 [0.75, 1.26]

0.99 [0.79, 1.25]

CP1

1.00 [0.74, 1.35]

1.00 [0.77, 1.30]

0.90 [0.70, 1.17]

0.87 [0.66, 1.15]

0.72 [0.56, 0.94]

0.68 [0.52, 0.88]

CP2

1.00 [0.75, 1.33]

0.98 [0.77, 1.26]

0.84 [0.65, 1.09]

0.72 [0.53, 0.98]

0.66 [0.50, 0.88]

Bendiocarb WP

WP1

1.00 [0.78, 1.27]

1.00 [0.78, 1.28]

1.00 [0.81, 1.24]

1.00 [0.76, 1.32]

0.53 [0.40, 0.69]

0.61 [0.46, 0.80]

WP2

1.00 [0.77, 1.29]

1.00 [0.76, 1.31]

1.00 [0.79, 1.27]

0.99 [0.76, 1.29]

0.47 [0.36, 0.63]

0.66 [0.51, 0.87]

CP1

1.00 [0.77, 1.31]

0.11 [0.06, 0.19]

0.02 [0.01, 0.07]

CP2

1.00 [0.76, 1.31]

0.05 [0.02, 0.11]

0.05 [0.02, 0.11]

Pirimiphos-Methyl CS

WP1

1.00 [0.78, 1.28]

1.00 [0.76, 1.32]

1.00 [0.80, 1.25]

0.98 [0.78, 1.24]

1.00 [0.79, 1.26]

1.00 [0.78, 1.28]

0.99 [0.78, 1.26]

0.97 [0.75, 1.26]

0.78 [0.62, 0.98]

WP2

1.00 [0.78, 1.28]

1.00 [0.76, 1.32]

0.94 [0.75, 1.17]

0.79 [0.62, 1.02]

0.84 [0.65, 1.08]

0.87 [0.68, 1.12]

0.74 [0.57, 0.96]

0.65 [0.49, 0.86]

CP1

1.00 [0.78, 1.27]

0.97 [0.76, 1.24]

0.99 [0.79, 1.24]

0.91 [0.72, 1.16]

0.70 [0.51, 0.95]

0.95 [0.74, 1.22]

0.64 [0.49, 0.84]

0.99 [0.77, 1.28]

0.90 [0.70, 1.16]

CP2

1.00 [0.78, 1.29]

0.97 [0.75, 1.25]

1.00 [0.80, 1.25]

0.98 [0.77, 1.24]

1.00 [0.78, 1.28]

0.98 [0.77, 1.24]

0.97 [0.77, 1.23]

0.92 [0.72, 1.17]

0.98 [0.76, 1.25]

  1. Italic entries indicate a statistical significance at 5% in the group comparison against the preceding month
  2. aThe experiments were maintained until a mortality rate of less than 80% was observed for two consecutive months